HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis.

AuthorsIoannis Mitroulis, Panagiotis Skendros, Anastasia Oikonomou, Athanasios G Tzioufas, Konstantinos Ritis
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 70 Issue 7 Pg. 1347-8 (Jul 2011) ISSN: 1468-2060 [Electronic] England
PMID21345814 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Interleukin-1beta
  • canakinumab
Topics
  • Adult
  • Antibodies, Monoclonal (therapeutic use)
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents (therapeutic use)
  • Arthritis (drug therapy)
  • Familial Mediterranean Fever (drug therapy)
  • Female
  • Humans
  • Interleukin-1beta (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: